baber/WOPTO huggingface dataset:
Patent NZ-591733-A (NZ)
Title: Recombinant newcastle disease virus comprising a transgene encoding a fusion protein comprising a binding domain and a heterologous domain comprising an enzyme
Inventor: BEIER RUDOLF
IPC: A61K35/76
Filed: 2005-11-10
Abstract: Disclosed is a recombinant oncolytic paramyxovirus comprising a nucleic acid with at least one transgene, wherein the nucleic acid of this transgene(s) codes for a binding protein that has a therapeutic activity when expressed by the virus-infected tumour cell and wherein the binding protein is a fusion protein comprising at least one binding domain and a heterologous domain comprising an enzyme; with the proviso that the binding protein is not an antibody molecule or a fragment or a derivative thereof.
Patent NZ-594503-A (NZ)
Title: Water treatment
Inventor: ATHANASIADIS KONSTANTINOS
IPC: C02F1/62
Filed: 2010-02-02
Abstract: 594503 Disclosed is an apparatus for treating run-off water. The apparatus includes a mechanical-sorption filter (311) for removing particulate and colloidal material, an ion exchange filter (312) for removing positively charged ions, such as heavy metals, and a sorption filter (313) for removing at least soluble contaminants, such as further heavy metals and arsenic. The mechanical-sorption filter includes polypropylene flakes. The ion exchange filter includes a zeolite filter material. The sorption filter includes a porous laterite filter material which provides the advantage of greater arsenic absorption. In use, the run-off water passes through the mechanical sorption filter, the ion exchange filter and the sorption filter in turn.
Patent NZ-598993-A (NZ)
Title: Multi-portion intra-oral dosage form with organoleptic properties
Inventor: HUGERTH ANDREAS
IPC: A61K9/24
Filed: 2010-03-26
Abstract: 598993 Disclosed is a multi-portion intra-oral unitary dosage form (such as a lozenge, a tablet, an oral film, a sublingual tablet, a troche, a lolly pop, a hard boiled candy, a chocolate lens, a micro bead, a wine gum, a semi solid, or a combination thereof) comprising at least two portions, each of said two portions containing: (a) at least one pharmaceutically active agent or health promoting agent, wherein said agent is suitable for intra-oral administration, and (b) a different added flavouring agent, wherein said flavoring agent is different than said active agent or health promoting agent, and wherein said flavouring agent signals the user of said dosage form that said pharmaceutically active agent or health promoting agent has started to be released from said portion, and wherein (c) the two portions have different dissolution rates, and the dissolution time for the portion with the slower dissolution rate is at least two times longer than for the portion with the faster dissolution rate, and (d) the portion with the faster dissolution rate comprises (i) a compressible excipient selected from isomalt, dextrose monohydrate, maltodextrin, lactose monohydrate, dextrin, mannitol, lactitol, sorbitol, xylitol, erythritol, sucrose and lactose, and mixtures thereof, and (ii) a water swellable excipient selected from sodium starch glycolate, crospovidone, croscarmellose, microcrystalline cellulose, starches, hydroxypropyl cellulose and alginic acid, and mixtures thereof; and (e) said intra-oral dosage form is not a chewing gum and does not contain a nicotine compound.
Patent NZ-601190-A (NZ)
Title: Biofuels from lignocellulosic resources
Inventor: BRAHMAJOSYULA JAGADEESH
IPC: C10L1/02
Filed: 2010-12-16
Abstract: Disclosed herein is a method comprising: separating a lignocellulosic resource into a substantially cellulosic portion and a substantially non-cellulosic portion; and fermenting the substantially cellulosic portion to produce microbial oil; pyrolyzing the substantially non-cellulosic portions to produce bio-oil or fermenting the substantially cellulosic portion to produce microbial oil and pyrolyzing the substantially non-cellulosic portion to produce bio-oil.
Patent NZ-602109-A (NZ)
Title: Plant protection agent
Inventor: STICH KARL
IPC: A01N35/06
Filed: 2011-02-24
Abstract: 602109 Disclosed is the use of a compound according to formula (A) or formula (B), where R1, R4 and R5 are H, a glycoside, or an ester independently of each other, as a plant protection agent, wherein the plant protection agent comprises the compound, which is dissolved in a solvent at a concentration of 0.1 uM to 2 mM. The compound is preferably extracted from Juglandaceae such as Juglans ailanthifolia (syn. sieboldiana) and used to treat Erwinia infections. Preferred compounds include: 5-hydroxy-1,4-naphthoquinone and 1,4,5-trihydroxynaphthalene
Patent NZ-603927-A (NZ)
Title: Apparatus and method for detecting disease in dairy animals
Inventor: GYONGY ISTVAN
IPC: A61B5/11
Filed: 2011-04-28
Abstract: Disclosed is an apparatus operable to detect udder disease in dairy animals. The apparatus is comprised of an accelerometer for attachment to a dairy animal and a processor operable to determine a measure of activity of a dairy animal to which the accelerometer is attached. The measure of activity is an index value associated with kinetic energy expended by the animal. Methods and computer programs for determing the index value are also disclosed.
Patent NZ-614333-A (NZ)
Title: Method for manufacturing ingredient for tea drink
Inventor: NAGAO KOJI
IPC: A23F3/06
Filed: 2012-02-17
Abstract: Disclosed is a method for manufacturing a tea drink ingredient, comprising: impregnating a tea drink ingredient with an aqueous amino acid solution that contains at least one amino acid selected from the group consisting of leucine, valine and isoleucine, and subjecting the impregnated tea drink ingredient to a heat treatment at a temperature of 100 to 200°C, wherein the tea drink ingredient is selected from the group consisting of tea leaves, barley or brown rice for tea.
Patent NZ-620523-A (NZ)
Title: Wire heated tube with temperature control system for humidifier for respiratory apparatus
Inventor: TANG ZHUO RAN
IPC: H05B3/40
Filed: 2014-01-30
Abstract: Disclosed is a control system for a heated conduit for use in a respiratory apparatus. The control system includes a power supply to provide power to the heated conduit and a heating control circuit (450) configured to control heating to obtain a predetermined temperature. A sensing circuit (428) includes a sensing resistor (426) configured to provide an output to indicate the temperature of a sensor positioned in the heated conduit. A bias generator circuit (418) provides a reference voltage to the sensing resistor (426) to allow determination of the temperature of the heated conduit as a function of a voltage drop across the sensing resistor (426) during both heating on and heating off cycles. A direction of the voltage drop across the sensing resistor (426) changes when the heating circuit (450) is on compared to when the heating circuit (450) is off.
Patent NZ-702029-A (NZ)
Title: Seismic isolation assembly
Inventor: RUAN SHUBIN
IPC: E04H9/02
Filed: 2014-11-17
Abstract: Wire rope isolators are sometimes used in an effort to decouple ground supported structures or apparatus from seismic compressive, tensile and shear loads from seismic activity. However in some applications particularly high-CG and/or eccentric structures, wire rope isolators may be unsuitable or insufficient. Disclosed herein, a seismic isolation assembly (100) is defined by a first support plate (104) and a second support plate (110) disposed in parallel relation with a spacing being provided between the support plates. The first support plate is connected to ground and the second support plate is attached to a structure to be isolated. A set of wire rope isolators (118) are disposed between the first and second support plates and at least one linear damper (160) is angularly disposed between the first and second support plates.
Patent NZ-706015-A (NZ)
Title: Operation communication system
Inventor: AHEARN JOHN ROBERT
IPC: G06F3/048
Filed: 2013-08-16
Abstract: There is provided a system, comprising: a mobile device, a reader device, and a cloud server. The reader device is configured to receive and process credential information. The cloud server is connectable to the reader device through the mobile device. The mobile device is configured to transmit a unique identifier of the reader device and a unique identifier of the mobile device to the cloud server, and the cloud server is configured to grant or deny access to the reader device through the mobile device in response to the unique identifier of the reader device and the unique identifier of the mobile device. The mobile device is configured to wirelessly communicate with the cloud server to receive at least one user interface configuration option and a policy that is based on a unique identifier of the reader device. The policy is pushed to the mobile device from the cloud server, and the mobile device is further configured to receive a user input to configure a personalized user interface configuration. The mobile device is further configured to wirelessly transmit the personalized user interface configuration to the reader device. The reader device is configured to receive the personalized user interface configuration from the mobile device, to implement the personalized user interface configuration, to receive additional information from the mobile device, and to perform a function based upon the additional information and the personalized user interface configuration and the policy.
Patent NZ-706531-A (NZ)
Title: Methods, systems, and apparatus for performing flow cytometry
Inventor: LUSCHER MARK
IPC: G01N21/64
Filed: 2012-02-15
Abstract: Disclosed is an apparatus and method for detecting an analyte in a fluidic sample. Flow cytometric sorting methods used to label and differentiate between cells can adversely affect the viability of the cells. The apparatus comprises an illumination source (151); concave collector element (146); closed flow cell and a detector (150). The illumination source (151) generates electromagnetic energy (149) to illuminate the sample at an interrogation region (148). The concave collector element (146) comprises a vertex; an optical axis and a focal point. The interrogation region (148) is coincident with the focal point of the concave collector element (146). The closed flow cell comprises a sample inlet; sample outlet and a flow path (138). The flow path (138) is defined between the sample inlet and outlet. The flow path (138) passes through the interrogation region (148) and a sorting region (152) disposed downstream of the interrogation region (148). The portion of the flow path (138) which passes through the interrogation region (148) is coaxially aligned with the optical axis of the concave collector element (146) and wherein at least the portion of the flow path (138) passing through the interrogation region (148) and the sorting region (152) is bounded by a flow cell wall to form a continuous closed flow path without division or bifurcation. The sample flows as a core-in-sheath flow or laminar flow at least through the interrogation region (148). The sample has a direction of flow moving from the interrogation region (148) towards the vertex of the collector element (146) or a direction of flow moving from the vertex of the collector (146) towards the interrogation region (148) and a portion of the flow path (138) passes through an internal volume of the collector element (146). The analyte generates a detectable signal in response to illumination. The detector (150) detects the detectable signal. The illumination source may be dispersed by a conical optical element (not labelled), reflected by a first (210) and second (212) concave optical elements to the interrogation region (148). The detectable signal generated from the interrogation region may be focused by the collector element (146) towards the detector (150). A pinhole element (216) may be placed at the focus of the transmitted energy to filter the detectable signal before being allowed to illuminate the detector (150).
Patent NZ-710744-A (NZ)
Title: Methods for increasing immunoglobulin a levels
Inventor: SMITH ERNEST S
IPC: C07K16/28
Filed: 2014-01-31
Abstract: Methods for decreasing the bacterial titre of a mucosal bacterial infection and increasing immunoglobulin A (IgA) levels in a subject having a deficiency thereof secondary to a mucosal bacterial infection, by administering to the subject an anti-CXCL13 antibody.
Patent NZ-710792-A (NZ)
Title: Tofacitinib oral sustained release dosage forms
Inventor: HERBIG SCOTT MAX
IPC: A61P37/06
Filed: 2014-03-12
Abstract: The present invention relates to oral sustained release formulations comprising a core comprising tofacitinib or a pharmaceutical acceptable salt thereof, and a semipermeable membrane coating surrounding the core, wherein said coating comprises a water-insoluble polymer, wherein the water-insoluble polymer is a cellulose derivative that sustains release of the tofacitinib. The formulations described herein have desirable pharmacokinetic characteristics, for example AUC, Cmax dose-adjusted AUC, dose-adjusted Cmax, and fed/fasted AUC and Cmax ratios.
Patent NZ-715687-A (NZ)
Title: Pyrimidine derivatives as kinase inhibitors
Inventor: XU XIAO
IPC: C07D403/12
Filed: 2014-07-11
Abstract: The present invention relates to pharmaceutical compounds, compositions and methods comprising compounds of Formula (Ia) as further described herein, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder, a cancer, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye or an immunologically related disease, and in some embodiments diseases or disorders related to the dysregulation of kinase such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, FLT3(D835Y), ITK, TEC, TXK, BTK, or JAK, and the respective pathways.
Patent NZ-716050-A (NZ)
Title: Device for dispensing yeast in a bakery and system for dispensing yeast in a bakery
Inventor: PICAVET FLORENT
IPC: F25D23/06
Filed: 2014-07-22
Abstract: The invention provides an improved device for dispensing yeast and an associated system for dispensing yeast. The device for dispensing liquid yeast, comprising: - an inner panel (2) of a refrigerated chamber (6), onto which is pre- mounted an inner circuit (20) for the flow of liquid yeast which is adapted to be connected to a liquid yeast vessel (4) and which comprises a pumping unit (21); - an outer panel (1) of the refrigerated chamber (6), onto which are pre-mounted: a liquid yeast metering device (16); a metering table (10) intended for receiving a container (3) to be filled with an amount of liquid yeast metered by said liquid yeast metering device (16); - said inner panel (2) and said outer panel (1) being structured so as to be attached sandwiched onto a wall (5) of a refrigerated chamber (6) within which said vessel (4) is located; - said liquid yeast metering device (16) being intended to be connected, through a wall (5) of the refrigerated chamber (6), to said inner circuit (20). This device proposes panels internal and external to the cold room, on which some or all of the necessary components are already pre-mounted, so that one only needs to attach these panels to either side of a wall of the cold room, reducing or minimizing the assembly operations performed on site during installation.
Patent NZ-716343-A (NZ)
Title: Musical sound generator
Inventor: LIAM BRYAN O’DALY
IPC: G10K1/076
Filed: 2014-04-14
Abstract: Disclosed is a musical sound generator (100) that generates random noise to provide a more relaxing environment. The generator comprises a tube (3) defining a resonant cavity, the tube comprising a plurality of sound producing chimes (4) configured to produce an audible sound when at least one object or plastic bead (2) impacts on at least one of the chimes; a reservoir (1) configured to hold a number of objects; and a transfer mechanism (7,7A,8,8A) configured to transfer the objects from the reservoir to an elevated position within the resonant cavity wherein the objects fall down from the elevated position within the resonant cavity by gravity after being transferred by the transfer mechanism, to strike the plurality of sound producing chimes to generate a continuous cycle of musical sounds at random intervals over time; a power source (9) and wherein a loading assistance means powered by the power source and configured to assist the uptake of the objects of the transfer mechanism from the reservoir. The loading assistance mechanism is configured to vary the position of the reservoir in relation to the transfer mechanism depending on the level of the objects held in the reservoir to improve uptake of the objects by the transfer mechanism from the reservoir. The transfer mechanism is a driven belt (7) configured with a plurality of paddles (7A) to capture and transfer the objects to the top of the tube. The tube is configured to rotate via a motor (3A) . The position of the reservoir in relation to the transfer mechanism is moved with at least one sensor configured to sense the level of the objects in the reservoir and at least one actuator configured to move the position of the reservoir via input from the at least one sensor.
Patent NZ-719739-A (NZ)
Title: Systems for treating pulmonary infections
Inventor: PERKINS WALTER
IPC: A61P31/04
Filed: 2013-05-21
Abstract: Provided herein are systems for treating a subject with a pulmonary infection, for example, a nontuberculous mycobacterial pulmonary infection, a Burkholderia pulmonary infection, a pulmonary infection associated with bronchiectasis, or a Pseudomonas pulmonary infection. The system includes a pharmaceutical formulation comprising a liposomal aminoglycoside dispersion, and the lipid component of the liposomes consist essentially of electrically neutral lipids. The system also includes a nebulizer which generates an aerosol of the pharmaceutical formulation at a rate greater than about 0.53 gram per minute. The aerosol is delivered to the subject via inhalation for the treatment of the pulmonary infection.
Patent NZ-725303-A (NZ)
Title: Anti-tumor agent containing taxane compound, and anti-tumor effect enhancer
Inventor: OKABE HIROYUKI
IPC: A61K31/337
Filed: 2015-04-03
Abstract: In order to provide a novel cancer treatment method using a FTD-TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD-TPI combination drug and a taxane compound are administered in combination.
Patent NZ-725360-A (NZ)
Title: Liquid pharmaceutical composition
Inventor: RINALDI GIANLUCA
IPC: C07K16/24
Filed: 2015-05-15
Abstract: The present invention relates to an aqueous pharmaceutical composition comprising: (a) adalimumab; (b) an acetate buffering agent or acetate buffer system; (c) a sugar stabiliser, wherein the sugar stabiliser is a non-reducing disaccharide selected from the group including trehalose and sucrose; and (d) polysorbate 80, wherein the composition: • has a pH between 5.0 and 5.5; • is either free of arginine or comprises arginine in a concentration of at most 0.1 mM; • is either free of phosphate buffering agents or comprises a phosphate buffer system in a concentration of at most 0.1 mM; • is either free of amino acids or comprises one or more amino acids in a collective concentration of at most 0.1 mM; and is either free of surfactants, with the exception of polysorbate 80, or comprises one or more of surfactants, excluding polysorbate 80, in a collective concentration of at most 0.001 mM. The invention also relates to a drug delivery device comprising the aqueous pharmaceutical composition, and manufacture of the aqueous pharmaceutical composition for treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, moderate to severe chronic psoriasis and/or juvenile idiopathic arthritis.
Patent NZ-743283-A (NZ)
Title: Expandable body device and method of use
Inventor: FRANANO F NICHOLAS
IPC: A61M29/02
Filed: 2014-03-17
Abstract: There is a need for medical devices, systems, and methods for treating saccular aneurysms, including cerebral aneurysms, which result in a more effective and complete reduction of blood flow to saccular aneurysms that is more effective in sealing the neck, and more durable and permanent. It is further desired to have medical devices, systems, and methods that reduce the flow of blood into saccular aneurysms and seals the aneurysm neck more quickly. Finally, it is desired to have medical devices, systems, and methods for treating saccular aneurysms that can be used more easily and in less time, with a lower risk of complications, and at a lower cost when compared with existing treatments. Disclosed herein are systems of two or more medical devices, which address the aforementioned problems, comprising a first medical device comprising, inter alia, a proximal hub and a first flexible cylindrical member defining a first lumen and a second flexible cylindrical member defining a second lumen, the first flexible cylindrical member and the second flexible cylindrical member being coaxial. The second medical device comprising inter alia, a coil, coiled wire, coiled metal wire, or second expandable body wherein, inter alia, a portion of the coil, coiled wire, coiled metal wire, or second expandable body of the second medical device contacts the wall of the expanded or inflated expandable body of the first medical device and a portion of the coil, coiled wire, coiled metal wire, or second expandable body of the second medical device contacts the wall of the space adjacent to the expanded or inflated expandable body of the first medical device, after placement.
Patent NZ-792157-A (NZ)
Title: Mask system
Inventor: DAVID JAMES LOCKWOOD
IPC: A61M16/06
Filed: 2009-02-27
Abstract: A mask system has a mask frame (1040) and a cushion (1060), and a stabilising member (1020) which attaches to the mask frame (1040). The mask system has a pair of upper headgear connectors (1024) each including a pair of upper arms (1026) extending under a patient’s eye and across the cheek. The upper arms (1026) is configured to in use prevent bending of the upper arms (1026) in a superior or inferior directions relative to the patient’s face.
Patent PT-115030-A (PT)
Title: Dispositivo de queimador para a utilização térmica de um combustível gaseiforme e processo para deteção de chama
Inventor: RICARDO LARANJEIRA
IPC: F23N5/00
Filed: 2018-09-20
Abstract: A INVENÇÃO REFERE-SE A UM DISPOSITIVO DE QUEIMADOR (10A, 10B) PARA A UTILIZAÇÃO TÉRMICA DE UM COMBUSTÍVEL GASEIFORME QUE COMPREENDE PELO MENOS UMA UNIDADE DE CÂMARAS DE PRÉMISTURA (14A; 14B) PARA UMA MISTURA DE UM COMBUSTÍVEL GASEIFORME (12A) COM UM GÁS CONTENDO OXIGÉNIO (16A), PARTICULARMENTE AR. É SUGERIDO QUE O DISPOSITIVO DE QUEIMADOR COMPREENDA PELO MENOS UMA UNIDADE DE DETEÇÃO DE CHAMA (18A; 18B) QUE COMPREENDE PELO MENOS UM ELEMENTO DE DETEÇÃO (20A; 20B) DISPOSTO NA UNIDADE DE CÂMARAS DE PRÉ-MISTURA (14A; 14B) PARA UMA DETEÇÃO DE UMA FORMAÇÃO DE CHAMA NO INTERIOR DA UNIDADE DE CÂMARAS DE PRÉ-MISTURA (14A; 14B). O PRESENTE PEDIDO DESCREVE TAMBÉM UM PROCESSO DE DETEÇÃO DE CHAMA.
Patent RU-94021154-A (RU)
Inventor: LATYPOV T T
IPC: E21B7/04
Filed: 1994-06-07
Abstract: FIELD: well drilling. SUBSTANCE: main shaft is drilled up to the deepest branching. Then the main shaft is cased by casing string, then additional shafts are drilled and cased. EFFECT: simplified technology. 1 dwg
Patent RU-94023449-A (RU)
Inventor: ZARETSKOV V V
IPC: A61B1/002
Filed: 1994-06-21
Abstract: FIELD: medicine, in particular, traumatology and orthopedics, can be used for objective diagnosis of rotatory deformity of vertebral column at its decreases. SUBSTANCE: the patient is placed on a coordinate plotting board so that the pelvic line coincides with one of the horizontal plane from top to bottom against the background of the coordinate plotting board, the line of suparms and pelvic line are plotted on the photograph, the angle between them is determined, and at an angle exceeding 5 deg. the rotatory deformity of the vertebral column is diagnosed. EFFECT: enhanced accuracy of diagnosis.